CLINICAL TRIAL

Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2026-07-17
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

Johns Hopkins University

Watch author

Derived topics and classifications

psilocybin Addiction Pharmacology Clinical Trial Randomized Controlled Trial Healthy Volunteers Healthcare Workers Adverse Events Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-07-21